Logo image
TIM-1 serves as a receptor for Ebola virus in vivo, enhancing viremia and pathogenesis
Journal article   Open access

TIM-1 serves as a receptor for Ebola virus in vivo, enhancing viremia and pathogenesis

Bethany Brunton, Kai Rogers, Elisabeth K Phillips, Rachel B Brouillette, Ruayda Bouls, Noah S Butler and Wendy Maury
PLoS neglected tropical diseases, Vol.13(6), pp.e0006983-e0006983
06/26/2019
DOI: 10.1371/journal.pntd.0006983
PMCID: PMC6615641
PMID: 31242184
url
https://doi.org/10.1371/journal.pntd.0006983View
Published (Version of record) Open Access

Abstract

T cell immunoglobulin mucin domain-1 (TIM-1) is one of a number of phosphatidylserine (PS) receptors that mediate clearance of apoptotic bodies by binding PS on the surface of dead or dying cells. Enveloped viruses mimic apoptotic bodies by exposing PS on the outer leaflet of the viral membrane. While TIM-1 has been shown to serve as an adherence factor/receptor for filoviruses in tissue culture, limited studies have investigated the role of TIM-1 as a receptor in vivo. Here, we sought to determine if TIM-1 was critical for Ebola virus glycoprotein-mediated infection using a BSL2 model virus. We demonstrate that loss of TIM-1 expression results in decreased virus load late during infection and significantly reduced virus-elicited mortality. These findings provide evidence that TIM-1 serves as an important receptor for Ebola virus in vivo. Blocking TIM-1/EBOV interactions may be effective antiviral strategy to reduce viral load and pathogenicity at late times of EBOV infection.
Medicine and Health Sciences Biology and life sciences Research and Analysis Methods

Details

Logo image